4th Quarter - Report
LOPER CONSULTING LLC for TEVA PHARMACEUTICALS USA
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R.2029 - Consolidated Appropriations Act, 2016 Lobbied on issues related to abuse deterrent formulations of drugs and prescription drug abuse FDA proposed rule on generic drug labels S. 484 and HR 1353 PATIENTS Act of 2015 Senate HELP working group on Innovation for Healthier Americans
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | Special Assistant to the President 2002-2005 |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.